Peter Schürmann

Peter Schürmann is …
instance of (P31):
humanQ5

External links are
P2038ResearchGate profile IDPeter-Schuermann
P1153Scopus author ID57209075563

P108employerHannover Medical SchoolQ911561
P106occupationresearcherQ1650915

Reverse relations

author (P50)
Q3601638611q13 is a susceptibility locus for hormone receptor positive breast cancer
Q371698739q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
Q64948510A Splice Site Variant of CDK12 and Breast Cancer in Three Eurasian Populations.
Q57250674A common coding variant in CASP8 is associated with breast cancer risk
Q39198367Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe
Q44712404Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy
Q47195947Assessment of a FBXW8 frameshift mutation, c.1312_1313delGT, in breast cancer patients and controls from Central Europe
Q40381692Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer
Q45979098Association analysis identifies 65 new breast cancer risk loci.
Q37292963Association of ESR1 gene tagging SNPs with breast cancer risk
Q62583329Association of chromosomal locus 8q24 and risk of prostate cancer: A hospital-based study of German patients treated with brachytherapy
Q96680596Association of genomic variants at the Human Leukocyte Antigen locus with cervical cancer risk, HPV status, and gene expression
Q35532898Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium
Q34327945Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
Q34793437CYP2B6*6 is associated with increased breast cancer risk
Q40756048Candidate gene variants of the immune system and sudden infant death syndrome.
Q31082788Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q34181322Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer
Q57278898Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q57250672Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk
Q90931747Evidence for an association of interferon gene variants with sudden infant death syndrome
Q47549687Exome sequencing and case-control analyses identify RCC1 as a candidate breast cancer susceptibility gene
Q91389910Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39
Q61230414Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes
Q92480972Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Q34979715Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium
Q101133544Genetic association study of fatal pulmonary embolism
Q36842233Genome-wide association analysis identifies three new breast cancer susceptibility loci
Q95329367Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
Q24645441Genome-wide association study identifies novel breast cancer susceptibility loci
Q34158129Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome
Q33330850Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics
Q36086247Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Q46103372Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Q40285577Limited role of interferon-kappa (IFNK) truncating mutations in common variable immunodeficiency
Q34123806Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls
Q30491647Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium
Q34460831Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer
Q37499453Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer
Q62583334NBS1 variant I171V and breast cancer risk
Q51908335Neuregulin-1 high-producer genotype is associated with a decreased risk of admission to the neonatal intensive care unit.
Q37356243Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Q43773075Nijmegen Breakage Syndrome mutations and risk of breast cancer
Q62583133Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q40728414Rare ATAD5 missense variants in breast and ovarian cancer patients

Search more.